Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance of Humira Injection in Korean Patients Under the "New-Drug Re-examination"

NCT01083121 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.

NCT NCT01083121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01083121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance of Humira Injection in Korean Patients Under the "New-Drug Re-examination"
Lead sponsor
AbbVie (prior sponsor, Abbott)
Phase
Observational
Overall status
Completed
Start date
April 30, 2007
Completion date
June 30, 2012
Enrollment
1,779 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, crohn's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis